Live tape
Top 8, mentions 7d10,382TSLA2,416 mentions▲ +0.05SPCX1,886 mentions▲ +0.08GOOGL1,298 mentions▲ +0.04CRWV1,186 mentions▲ +0.04NVDA1,045 mentions▲ +0.07QQQ1,010 mentions▲ +0.05META776 mentions▲ +0.05NBIS765 mentions▲ +0.07

Equity · Healthcare

QDEL

NASDAQ

QuidelOrtho (QDEL)

$17.38 −4.69% vs prior close Finazon · prior-day close, indicative (IEX-derived, not the official close)
Price · Chart

This price chart is drawn by TradingView, from their own data, in an embed loaded from their servers. We hold too few licensed daily closes of our own for QDEL to draw a line in its place.

Track this symbol on TradingView TradingView chart
Market cap $1.2B
52-week range $9.95 – $35
Avg volume 386.7K

as of Jul 17, 2026

QuidelOrtho (QDEL) insider trades

SEC Form 4 · last 90 days · newest Form 4 filing 15 Oct 2026

In the 90 days to 21 Oct 2026, no QuidelOrtho insider bought or sold shares on the open market; all 6 Form 4 filings in that window were grants, exercises, tax withholding or transfers (SEC Form 4).

Open-market buys 0
Open-market sells 0
Non-trade filings 6

Compensation mechanics Share grants, option exercises, tax withholding and transfers. They reach the same Form 4 as a trade, but they are not the insider buying or selling on the open market, so no purchase or sale value applies to them.

Date Insider Type Shares Value
15 Oct 2026 Siegrist Jonathan Philip EVP of R&D & CTO Option exercise 18,657
15 Oct 2026 Siegrist Jonathan Philip EVP of R&D & CTO Tax withheld 6,695 $93K
15 Sep 2026 Bowman Ronald Lee Chief Human Resources Officer Option exercise 2,566
15 Sep 2026 Bowman Ronald Lee Chief Human Resources Officer Tax withheld 921 $10K
15 Aug 2026 Hanson Bryan Michael EVP Global Port. Mgmt & Mkting Option exercise 446
15 Aug 2026 Hanson Bryan Michael EVP Global Port. Mgmt & Mkting Tax withheld 162 $2K

QuidelOrtho (QDEL) reported financials

SEC EDGAR XBRL SEC EDGAR

QuidelOrtho reported revenue of $2.7B for the fiscal year ended 28 Dec 2025. Net income over the same period was −$1.1B.

Figure Reported Period
Revenue $2.7B 28 Dec 2025 fiscal year
Net income −$1.1B 28 Dec 2025 fiscal year
Diluted EPS −$16.69 28 Dec 2025 fiscal year
Total assets $5.7B 28 Jun 2026 at period end
Total equity $1.8B 28 Jun 2026 at period end

QuidelOrtho (QDEL) earnings

SEC EDGAR

QuidelOrtho last reported earnings on 28 Jun 2026 for Q2 2026, with EPS of −$1.36; no next date is announced in SEC filings yet.

Date Period EPS Revenue
28 Jun 2026 Q2 2026 −$1.36 $631M
29 Mar 2026 Q1 2026 −$1.35 $620M
28 Dec 2025 FY 2025 −$16.69 $2.73B
28 Sep 2025 Q3 2025 −$10.78 $700M
29 Jun 2025 Q2 2025 −$3.77 $614M
30 Mar 2025 Q1 2025 −$0.19 $693M
29 Dec 2024 FY 2024 −$30.54 $2.78B
29 Sep 2024 Q3 2024 −$0.30 $727M

Next report no date announced in SEC filings yet

Reported figures & scheduled dates · SEC EDGAR filings

QuidelOrtho (QDEL) institutional holders (13F)

SEC Form 13F SEC EDGAR

8 of the 45 institutional funds we track reported a QuidelOrtho position for the quarter ended 30 Jun 2026 — a combined $45.0M; the latest of those filings landed 14 Aug 2026.

Fund Action Shares Value
AQR Capital Management Added +421.5% shares 911,115 $16.0M
Millennium Management Added +156.0% shares 722,480 $12.7M
D. E. Shaw & Co. Held (±25%) −1.6% shares 270,233 $4.7M
GAMCO Investors Held (±25%) −1.0% shares 251,235 $4.4M
Tudor Investment Corp Held (±25%) −16.9% shares 194,953 $3.4M
Marshall Wace Added +30.8% shares 172,500 $3.0M
Point72 Asset Management Trimmed −96.0% shares 30,422 $533K
Two Sigma Investments New position 17,402 $305K

QuidelOrtho (QDEL) fails-to-deliver

SEC CNS data SEC

On 22 Sep 2026, 110 shares of QuidelOrtho failed to deliver (about $1K).

Settlement date Shares failed Notional % of shares out
22 Sep 2026 110 $1K <0.001%

Congressional trades in QuidelOrtho (QDEL)

STOCK Act disclosures House disclosures

The most recent congressional trade disclosed in QuidelOrtho is a sale by Daniel S. Goldman (house, NY), dated 12 Jul 2023.

Date Member Type Amount
12 Jul 2023 filed 13 Aug 2023 Daniel S. Goldman house · Democrat–NY Sale $1K–$15K

QuidelOrtho (QDEL): frequently asked questions

From live data

Have QuidelOrtho insiders bought or sold shares recently?

In the 90 days to 21 Oct 2026, no QuidelOrtho insider bought or sold shares on the open market; all 6 Form 4 filings in that window were grants, exercises, tax withholding or transfers (SEC Form 4).

How many institutions hold QuidelOrtho?

8 of the 45 institutional funds we track reported a QuidelOrtho position for the quarter ended 30 Jun 2026, per SEC Form 13F filings.

Has QuidelOrtho had fails-to-deliver recently?

Yes. The most recent SEC fails-to-deliver record for QuidelOrtho is dated 22 Sep 2026, when 110 shares failed to deliver.

When did QuidelOrtho last report earnings?

QuidelOrtho last reported earnings on 28 Jun 2026 for Q2 2026, with EPS of −$1.36; no next date is announced in SEC filings yet.

What exchange is QuidelOrtho listed on?

QuidelOrtho trades on NASDAQ under the ticker QDEL.

Answers are generated from the live figures on this page — Reddit crowd data, SEC filings and open company records — and update as the data does.

Sources

  1. Finazonprior-day close, indicative (IEX-derived, not the official close)
  2. TradingViewthe price chart widget, drawn by TradingView from their own data
  3. SEC EDGARSEC EDGAR XBRL company facts · latest period ended 28 Jun 2026
  4. SEC EDGARSEC EDGAR 13F filings
  5. SECSEC fails-to-deliver (CNS) data
  6. House disclosuresU.S. House of Representatives financial disclosures
  7. SEC EDGARValuation computed from SEC EDGAR filings